MEK-ERK Signaling is a Therapeutic Target in Metastatic Castration Resistant Prostate Cancer
Nicholas G. Nickols,Ramin Nazarian,Shuang G. Zhao,Victor Tan,Vladislav Uzunangelov,Zheng Xia,Robert Baertsch, Elad Neeman,Allen C. Gao,George Thomas,Lauren Howard,Amanda M. De Hoedt,Josh Stuart,Theodore Goldstein,Kim Chi,Martin E. Gleave,Julie N. Graff,Tomasz M. Beer,Justin M. Drake,Christopher P. Evans,Rahul Aggarwal,Adam Foye,Felix Y. Feng,Eric J. Small,William J. Aronson,Stephen J. Freedland,Owen N. Witte,Jiaoti Huang,Joshi J. Alumkal,Robert E. Reiter,Matthew B. Retti PROSTATE CANCER AND PROSTATIC DISEASES（2019）
Key words
Metastatic Prostate Cancer,MEK Inhibition,Cancer Therapy,Cancer,ERK pathway
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper